Study identifier:NIS-NEU-SER-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
European study to describe hospital stay in patients admitted for acute bipolar manic episodes treated with immediate release quetiapine or extended release quetiapine
acute bipolar manic episode
-
No
-
All
1280
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
1 patients admitted as for an acute bipolar manic episode and treated with quetiapine IR | - |
2 patients admitted as for an acute bipolar manic episode and treated with quetiapine XR | - |